1. Current trends of targeted therapy for oral squamous cell carcinoma

   • Hongjiao Li
   • Yao Zhang
   • Deqin Yang

   Review – Cancer Research 02 May 2022 Pages: 2169 - 2186

   

2. Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis

   • Roberto Falz
   • Christian Bischoff
   • Ines Gockel

   Review – Cancer Research Open access 13 June 2022 Pages: 2187 - 2213

   

3. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression

   • Rui Liu
   • Yachun Jia
   • Aili He

   Review – Cancer Research 28 June 2022 Pages: 2215 - 2230

   

4. Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer

   • Christian D. Fankhauser
   • Hielke M. de Vries
   • Vijay Sangar

   Original Article – Cancer Research 12 April 2022 Pages: 2231 - 2234

   

5. Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis

   • Sarah Krieg
   • Christoph Roderburg
   • Andreas Krieg

   Original Article – Cancer Research Open access 15 April 2022 Pages: 2235 - 2246

   

6. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer

   • Xing Tang
   • Haolin Huang
   • Xiaopan Xu

   Original Article – Cancer Research 17 April 2022 Pages: 2247 - 2260

   

7. CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer

   • Hongjia Zhu
   • Xiaoyan Fang
   • Lei Yu

   Original Article – Cancer Research 21 April 2022 Pages: 2261 - 2274

   

8. R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition

   • Thomas K. Sears
   • Kevin D. Woolard

   Original Article – Cancer Research Open access 25 April 2022 Pages: 2275 - 2285

   

9. Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma

   • Alexander Damanakis
   • Patrick Sven Plum
   • Alexander Quaas

   Original Article – Cancer Research Open access 27 April 2022 Pages: 2287 - 2293

   

10. Inflammation suppresses DLG2 expression decreasing inflammasome formation

    • Simon Keane
    • Matthew Herring
    • Katarina Ejeskär

    Original Article – Cancer Research Open access 02 May 2022 Pages: 2295 - 2311

    

11. Single-cell transcriptome highlights a multilayer regulatory network on an invasive trajectory within colorectal cancer progression

    • Tong Zhou
    • Chunhua Li

    Original Article – Cancer Research 06 May 2022 Pages: 2313 - 2322

    

12. Fragmentation of care and colorectal cancer survival in South Korea: comparisons according to treatment at multiple hospitals

    • Dong-Woo Choi
    • Seungju Kim
    • Kyu-Tae Han

    Original Article – Cancer Research 06 May 2022 Pages: 2323 - 2333

    

13. The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

    • Man Yi Li
    • Le Mi
    • Zhi Long Chen

    Original Article – Cancer Research 06 May 2022 Pages: 2335 - 2346

    

14. Liquid biopsy: early and accurate diagnosis of brain tumor

    • Zhenjie Yi
    • Chunrun Qu
    • Zhixiong Liu

    Review – Clinical Oncology 22 April 2022 Pages: 2347 - 2373

    

15. Liposomal formulations for lung cancer treatment in the last two decades: a systematic review

    • Filipa Canão
    • Helena Ferreira
    • Nuno M. Neves

    Review – Clinical Oncology 04 June 2022 Pages: 2375 - 2386

    

16. Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention

    • Wenjie Zhang
    • Jie Zhang
    • Dong Tang

    Review – Clinical Oncology 04 June 2022 Pages: 2387 - 2404

    

17. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety

    • So Jung Lee
    • Myungsoo Kim
    • Hye Jin Kang

    Original Article – Clinical Oncology 06 September 2021 Pages: 2405 - 2414

    

18. Predictors for thromboembolism in patients with cholangiocarcinoma

    • Christian Pfrepper
    • Maren Knödler
    • Florian Lordick

    Original Article – Clinical Oncology Open access 09 September 2021 Pages: 2415 - 2426

    

19. The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

    • Hana Kim
    • Soomin Ahn
    • Seung Tae Kim

    Original Article – Clinical Oncology Open access 12 September 2021 Pages: 2427 - 2435

    

20. Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study

    • Kenji Morimoto
    • Junji Uchino
    • Koichi Takayama

    Original Article – Clinical Oncology 12 September 2021 Pages: 2437 - 2446

    

21. Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer

    • Cecilia Pompili
    • Sanjush Dalmia
    • Galina Velikova

    Original Article – Clinical Oncology Open access 13 September 2021 Pages: 2447 - 2454

22. Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments

    • Shota Omori
    • Koji Muramatsu
    • Toshiaki Takahashi

    Original Article – Clinical Oncology 17 September 2021 Pages: 2455 - 2463

    

23. Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants

    • Yaqi Zhong
    • Qing Wu
    • Xianhe Xie

    Original Article – Clinical Oncology 17 September 2021 Pages: 2465 - 2474

    

24. A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

    • Xin Tang
    • Yuan Li
    • Zhi-gang Yang

    Original Article – Clinical Oncology 18 September 2021 Pages: 2475 - 2486

    

25. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

    • Osman Öcal
    • Daniel Rössler
    • Max Seidensticker

    Original Article – Clinical Oncology Open access 20 September 2021 Pages: 2487 - 2496

    

26. Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms

    • A. Dascalu
    • B. N. Walker
    • E. O. David

    Original Article – Clinical Oncology Open access 21 September 2021 Pages: 2497 - 2505

    

27. Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era

    • Wonchul Lee
    • Wook Nam
    • Bumsik Hong

    Original Article – Clinical Oncology 23 September 2021 Pages: 2507 - 2515

    

28. Clinical study of MAP2K1-mutated Langerhans cell histiocytosis in children

    • Ying Yang
    • Chanjuan Wang
    • Tianyou Wang

    Original Article – Clinical Oncology 30 September 2021 Pages: 2517 - 2527

    

29. Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients

    • Sofia Verkhovskaia
    • Francesca Romana Di Pietro
    • Cristina Fortes

    Original Article – Clinical Oncology 30 September 2021 Pages: 2529 - 2538

    

30. Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

    • Regina Mühleck
    • Sebastian Scholl
    • Ulf Schnetzke

    Original Article – Clinical Oncology Open access 05 October 2021 Pages: 2539 - 2548

    

31. Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial

    • Weimin Liu
    • Juan Liu
    • Jing Chen

    Research Open access 05 July 2022 Pages: 2549 - 2560

    

32. Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion

    • Xuehua Xie
    • Mengxing You
    • Weiming Huang

    Letter to the Editors Open access 01 June 2022 Pages: 2561 - 2566

    

33. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al

    • Ozan Cem Guler
    • Cem Onal

    Letter to the Editors 13 June 2022 Pages: 2567 - 2568